Mission Statement
Abliva develops medicines for the treatment of mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell’s energy provider, the mitochondria, do not function properly. The portfolio includes projects at different stages and ranges from early discovery phase to clinical phase.
On the web
Website: https://abliva.com/